Skip to McMaster Navigation Skip to Site Navigation Skip to main content
McMaster logo

Cures Within Reach: Impacting Blood Cancers through Clinical Repurposing Trials

Research Admin Offices:

  • HRS

Funding Type:


Opportunity Type:

  • Grant


Up to $60,000 US, plus an institutional match of 20%.


  • Health Sciences



Internal Deadline:

July 15, 2024

Sponsor Deadline:

July 29, 2024

Additional Dates:

  • LOI HRS Due Date - July 15, 2024
  • LOI Sponsor Due Date - July 29, 2024


This opportunity supports clinical repurposing trials to address unsolved blood cancers, with a preference for trials impacting multiple myeloma and/or myelodysplastic syndromes. Of specific interest is generic or proprietary approved therapies that could be repurposed to create “new” treatments to 1) reduce the symptoms, progression or incidence of; 2) restore function lost to; or 3) reduce or eliminate severe side effects of currently used therapies for any blood cancer, thereby improving patient outcomes and quality of life.


Additional Details.


If applying from the Faculty of Health Sciences, unless otherwise indicated, you no longer need to send documents to HRS Intake. Your first point of contact is your assigned Senior Grants Advisor.